import type { BlogArticle } from '../blog-types';

export const article: BlogArticle = {
  slug: "hexarelin-cardiac-gh-research-overview",
  title: "Hexarelin: Cardiac Effects and GH Secretagogue Research Overview",
  description:
    "Overview of hexarelin's dual research profile — as a potent GH secretagogue and as a GH-independent cardioprotective agent via CD36. Study findings, mechanisms, and protocol considerations.",
  category: "Compound Profiles",
  readMinutes: 9,
  publishedAt: "2026-06-04",
  ogImage: "/og-image.jpg",
  body: [
    {
      type: "disclaimer",
      text: "Hexarelin is a research chemical for licensed researchers and scientific educators only. Not intended for human use.",
    },
    {
      type: "paragraph",
      text: "Hexarelin occupies a unique position in peptide research: it is simultaneously one of the most potent growth hormone secretagogues in the GHS-R1a agonist class and one of the best-characterized cardioprotective peptides in preclinical cardiovascular research. These two biological activities are mechanistically distinct, which makes hexarelin both scientifically interesting and practically complex to study.",
    },
    {
      type: "heading",
      text: "GH Secretagogue Profile",
    },
    {
      type: "paragraph",
      text: "Hexarelin is a synthetic hexapeptide (His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2) and a potent GHS-R1a agonist. In comparative studies, it demonstrates significantly stronger GH stimulation than GHRP-6 or ipamorelin on a molar basis. This potency makes it useful for GH axis research but also introduces a key limitation: hexarelin desensitizes GHS-R1a receptors more rapidly than other secretagogues, limiting the utility of continuous-dosing protocols.",
    },
    {
      type: "paragraph",
      text: "Research comparing hexarelin to other GH secretagogues has consistently shown it produces robust GH pulses but with significant cortisol and prolactin co-release — a property that distinguishes it from selective agents like ipamorelin and makes study interpretation more complex.",
    },
    {
      type: "heading",
      text: "GH-Independent Cardiac Activity",
    },
    {
      type: "paragraph",
      text: "Separate from its GHS activity, hexarelin binds with high affinity to CD36 — a scavenger receptor expressed in cardiomyocytes, macrophages, and vascular endothelium. This interaction triggers protective signaling cascades that are active even in hypophysectomized (pituitary-removed) animal models, confirming independence from GH release.",
    },
    {
      type: "paragraph",
      text: "Documented cardiac research findings include: reduced myocardial infarct size in I/R injury models, preservation of left ventricular function after ischemic challenge, reduced cardiomyocyte apoptosis, and anti-inflammatory modulation of cytokine release in cardiac tissue.",
    },
    {
      type: "heading",
      text: "Comparative Research Context",
    },
    {
      type: "paragraph",
      text: "Among GHRP-class peptides, hexarelin is the only one with documented CD36-mediated cardiac activity at the research level. GHRP-2, GHRP-6, and ipamorelin activate GHS-R1a but do not appear to share hexarelin's degree of CD36 affinity. This makes hexarelin the preferred agent for researchers specifically studying cardiac protection mechanisms, while ipamorelin remains preferred for clean GH axis research where hormonal confounds need to be minimized.",
    },
    {
      type: "heading",
      text: "Dosing in Preclinical Research",
    },
    {
      type: "table",
      headers: ["Research Application", "Common Dose Range", "Route"],
      rows: [
        ["GH secretion studies", "100–300 µg/kg", "SC or IV"],
        ["Cardiac I/R protection models", "80–200 µg/kg", "IV or IP"],
        ["Chronic desensitization studies", "Cycling protocols", "SC"],
      ],
    },
    {
      type: "callout",
      text: "Nexphoria provides hexarelin with batch-specific HPLC and MS COAs, LAL endotoxin testing, and cold-chain delivery to preserve compound stability.",
    },
  ],
};
